ArticleGenetics2026
Impact of naturally occurring target-site polymorphisms on an autonomous Cas9/guide RNA-based gene drive system for population modification of Anopheles gambiae s.l.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Malaria remains a significant global health challenge with an estimated 282 million cases reported in 2024. CRISPR/Cas9-based gene-drive systems have emerged as promising tools to block Plasmodium transmission by mosquito vectors. The TP13 drive system targets the Anopheles gambiae cardinal (Agcd) gene and carries 2 engineered monoclonal antibodies to achieve rapid population modification to prevent parasite transmission. Previous cage trials demonstrated complete drive introduction in 3 to 6 generations and supported modeling predicting a potential >90% reduction in malaria incidence under optimal conditions. However, naturally-occurring genetic polymorphisms in wild mosquito populations, particularly single-nucleotide polymorphisms (SNPs) within Cas9/guide RNA target sites, pose a potential barrier to drive efficiency. High genetic diversity in An. gambiae results in drive-system target-site variants, including an A→T transversion in the Agcd gene, which occurs at high frequencies in African populations and could affect TP13 drive dynamics. The impact of this and other SNPs on TP13 performance were assessed by establishing 3 An. gambiae Ndokayo lines, 1 with the wild-type Agcd and 2 with homozygous SNP haplotypes. We evaluated drive conversion rates in vivo, population dynamics in cage trials, fitness costs, and parasite suppression efficacy. No negative effects on drive performance and parasite suppression were observed. The results provide insights into the influence of naturally-occurring polymorphisms on gene drive propagation, informing safety, efficacy, and target product profile requirements for advancing gene-drive mosquitoes toward field trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.